These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38225942)

  • 1. Implementation bottlenecks of real time medication monitoring (evriMED) for improving adherence to anti-TB drugs among people with tuberculosis in Kilimanjaro, Tanzania.
    Anenmose Maro R; Mtenga A; Mtesha B; Wilhelm K; Lekashingo N; Sumari-de Boer M; Ngowi K
    J Clin Tuberc Other Mycobact Dis; 2024 Feb; 34():100409. PubMed ID: 38225942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of a Digital Adherence Tool Among Patients With Tuberculosis and Tuberculosis Care Providers in Kilimanjaro Region, Tanzania: Mixed Methods Study.
    Mtenga AE; Maro RA; Dillip A; Msoka P; Emmanuel N; Ngowi K; Sumari-de Boer M
    Online J Public Health Inform; 2024 Jun; 16():e51662. PubMed ID: 38922643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial.
    Sumari-de Boer M; Pima FM; Ngowi KM; Chelangwa GM; Mtesha BA; Minja LM; Semvua HH; Mpagama S; Mmbaga BT; Nieuwkerk PT; Aarnoutse RE
    Trials; 2019 Jul; 20(1):426. PubMed ID: 31300028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of using the medication monitor and experience of a differentiated care approach for TB treatment adherence among people living with TB in South Africa.
    Mukora R; Ahumah B; Maraba N; Orrell C; Jennings L; Naidoo P; Fielding KL; Velen K; Charalambous S; Chetty-Makkan CM
    PLOS Glob Public Health; 2023; 3(10):e0001885. PubMed ID: 37889875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa.
    Mukora R; Maraba N; Orrell C; Jennings L; Naidoo P; Mbatha MT; Velen K; Fielding K; Charalambous S; Chetty-Makkan CM
    BMJ Open; 2023 Mar; 13(3):e065202. PubMed ID: 36868589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial.
    Maraba N; Orrell C; Chetty-Makkan CM; Velen K; Mukora R; Page-Shipp L; Naidoo P; Mbatha MT; Fielding KL; Charalambous S
    Trials; 2021 Jun; 22(1):389. PubMed ID: 34108036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "I Wish to Continue Receiving the Reminder Short Messaging Service": A Mixed Methods Study on the Acceptability of Digital Adherence Tools Among Adults Living with HIV on Antiretroviral Treatment in Tanzania.
    Ngowi K; Pima F; Mmbaga BT; Aarnoutse RE; Reiss P; Nieuwkerk PT; Sprangers M; Sumari-de Boer M
    Patient Prefer Adherence; 2021; 15():559-568. PubMed ID: 33727801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital Adherence Technologies and Differentiated Care for Tuberculosis Treatment and Their Acceptability Among Persons With Tuberculosis, Health Care Workers, and Key Informants in the Philippines: Qualitative Interview Study.
    Leung CL; Alacapa J; Tasca BG; Villanueva AD; Masulit S; Ignacio ML; Uy KN; Pell C; van Kalmthout K; Powers R; Fielding K; Jerene D
    JMIR Hum Factors; 2024 Jul; 11():e54117. PubMed ID: 39042889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability, Usefulness, and Ease of Use of an Enhanced Video Directly Observed Treatment System for Supporting Patients With Tuberculosis in Kampala, Uganda: Explanatory Qualitative Study.
    Sekandi JN; McDonald A; Nakkonde D; Zalwango S; Kasiita V; Kaggwa P; Kakaire R; Atuyambe L; Buregyeya E
    JMIR Form Res; 2023 Nov; 7():e46203. PubMed ID: 37948121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
    Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
    J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers.
    Thomas BE; Kumar JV; Onongaya C; Bhatt SN; Galivanche A; Periyasamy M; Chiranjeevi M; Khandewale AS; Ramachandran G; Shah D; Haberer JE; Mayer KH; Subbaraman R
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e16634. PubMed ID: 32735220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study.
    Leddy A; Ggita J; Berger CA; Kityamuwesi A; Sanyu AN; Tinka LK; Crowder R; Turyahabwe S; Katamba A; Cattamanchi A
    J Med Internet Res; 2023 May; 25():e38828. PubMed ID: 37252774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors related to the utilization of digital adherence technologies in tuberculosis care: A qualitative study among adults in DS-TB treatment, health care providers and other key actors in Tanzania.
    Gonçalves Tasca B; Mganga A; Leung CL; Shilugu L; Pell C; Onjare B; Luvanda N; Mleoh L; de Groot L; van Kalmthout K; Fielding K; Jerene D
    PLOS Glob Public Health; 2024; 4(8):e0002795. PubMed ID: 39116120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical and Psychosocial Challenges of mHealth Usage for Antiretroviral Therapy Adherence Among People Living With HIV in a Resource-Limited Setting: Case Series.
    Ngowi KM; Lyamuya F; Mmbaga BT; Muro E; Hillu Z; Shirima M; Aarnoutse RE; Ag Sprangers M; Nieuwkerk PT; Reiss P; Sumari-de Boer M
    JMIR Form Res; 2020 Jun; 4(6):e14649. PubMed ID: 32519966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital Adherence Technologies and Mobile Money Incentives for Management of Tuberculosis Medication Among People Living With Tuberculosis: Mixed Methods Formative Study.
    Musiimenta A; Tumuhimbise W; Atukunda E; Mugaba A; Linnemayr S; Haberer J
    JMIR Form Res; 2023 Apr; 7():e45301. PubMed ID: 37043263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study.
    Musiimenta A; Tumuhimbise W; Mugaba AT; Muzoora C; Armstrong-Hough M; Bangsberg D; Davis JL; Haberer JE
    J Clin Tuberc Other Mycobact Dis; 2019 Dec; 17():100119. PubMed ID: 31788561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.
    Subbaraman R; de Mondesert L; Musiimenta A; Pai M; Mayer KH; Thomas BE; Haberer J
    BMJ Glob Health; 2018; 3(5):e001018. PubMed ID: 30364330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials.
    Ridho A; Alfian SD; van Boven JFM; Levita J; Yalcin EA; Le L; Alffenaar JW; Hak E; Abdulah R; Pradipta IS
    J Med Internet Res; 2022 Feb; 24(2):e33062. PubMed ID: 35195534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a customized digital adherence tool on retention in care and adherence to antiretroviral treatment in breastfeeding women, children and adolescents living with HIV in Tanzania: a mixed-methods study followed by clinical trials.
    Sumari-de Boer IM; Ngowi KM; Swai IU; Masika LV; Maro RA; Mtenga AE; Mtesha BA; Nieuwkerk PT; Reis R; de Wit TFR; Aarnoutse RE
    Trials; 2023 Apr; 24(1):285. PubMed ID: 37085913
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.